Joshua Fitch

The newly FDA-approved prescription product delivers nalmefene to the nasal cavity to reverse the effects of opioid overdose.

The trial also revealed that nirsevimab reduced the incidence of hospitalizations due to severe RSV-related LRTD by 75.1%.

While acknowledging remaining uncertainties posed by potential evolution of SARS-CoV-2, the organization advised it’s time to transition to long-term management of the pandemic.

The MiniMed 780G has been available in Europe since 2020.

A new study examines whether anakinra can reduce inflammation and the need for mechanical ventilation in patients with severe COVID-19 pneumonia.

The drug, called Atovaquone, has been voluntarily recalled due to possible Bacillus cereus contamination.

Data reveal 50% of meningitis vaccination appointments were delayed or canceled amid the COVID-19 pandemic, leading authors of a survey to highlight the need for “urgent action” to maintain routine vaccination levels among children.

The drug, called Leniolisib, is the first and only treatment approved in the United States for APDS, a rare primary immunodeficiency.

Dupilumab met both its primary and key secondary endpoints in a phase 3 trial, demonstrating efficacy as a potential treatment for atopic hand and foot dermatitis.